Royal Bank Of Canada Cocrystal Pharma, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
About Cocrystal Pharma, Inc.
- Ticker COCP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,122,420
- Market Cap $21.3M
- Description
- Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...